These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15914522)

  • 1. Effect of insulin on plasma vascular endothelial growth factor in children with new-onset diabetes.
    Ashraf A; Mick G; Meleth S; Abdullatif H; Wang X; McCormick K
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4920-3. PubMed ID: 15914522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control.
    Singh K; Sandler S; Espes D
    J Diabetes Res; 2017; 2017():6192896. PubMed ID: 28421206
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycaemic control, markers of endothelial cell activation and oxidative stress in children with type 1 diabetes mellitus.
    Seckin D; Ilhan N; Ilhan N; Ertugrul S
    Diabetes Res Clin Pract; 2006 Aug; 73(2):191-7. PubMed ID: 16442660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients.
    Kakizawa H; Itoh M; Itoh Y; Imamura S; Ishiwata Y; Matsumoto T; Yamamoto K; Kato T; Ono Y; Nagata M; Hayakawa N; Suzuki A; Goto Y; Oda N
    Metabolism; 2004 May; 53(5):550-5. PubMed ID: 15131756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications.
    Chiarelli F; de Martino M; Mezzetti A; Catino M; Morgese G; Cuccurullo F; Verrotti A
    J Pediatr; 1999 Apr; 134(4):486-91. PubMed ID: 10190925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF levels in plasma in relation to platelet activation, glycemic control, and microvascular complications in type 1 diabetes.
    Schlingemann RO; Van Noorden CJ; Diekman MJ; Tiller A; Meijers JC; Koolwijk P; Wiersinga WM
    Diabetes Care; 2013 Jun; 36(6):1629-34. PubMed ID: 23321217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and Plasma Levels of Vascular Endothelial Growth Factors in Relation to Quality of Glucose Control, Biomarkers of Inflammation, and Diabetic Nephropathy.
    Hanefeld M; Appelt D; Engelmann K; Sandner D; Bornstein SR; Ganz X; Henkel E; Haase R; Birkenfeld AL
    Horm Metab Res; 2016 Aug; 48(8):529-34. PubMed ID: 27388431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
    Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry.
    Clements MA; Foster NC; Maahs DM; Schatz DA; Olson BA; Tsalikian E; Lee JM; Burt-Solorzano CM; Tamborlane WV; Chen V; Miller KM; Beck RW;
    Pediatr Diabetes; 2016 Aug; 17(5):327-36. PubMed ID: 26153338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.
    Weintrob N; Schechter A; Benzaquen H; Shalitin S; Lilos P; Galatzer A; Phillip M
    Arch Pediatr Adolesc Med; 2004 Jul; 158(7):677-84. PubMed ID: 15237068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose.
    Paterson AD; Waggott D; Boright AP; Hosseini SM; Shen E; Sylvestre MP; Wong I; Bharaj B; Cleary PA; Lachin JM; ; Below JE; Nicolae D; Cox NJ; Canty AJ; Sun L; Bull SB;
    Diabetes; 2010 Feb; 59(2):539-49. PubMed ID: 19875614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor during hypoglycemia in patients with type 1 diabetes mellitus: relation to cognitive function and renin-angiotensin system activity.
    Kristensen PL; Høi-Hansen T; Boomsma F; Pedersen-Bjergaard U; Thorsteinsson B
    Metabolism; 2009 Oct; 58(10):1430-8. PubMed ID: 19573885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.
    Cengiz E; Cheng P; Ruedy KJ; Kollman C; Tamborlane WV; Klingensmith GJ; Gal RL; Silverstein J; Lee J; Redondo MJ; Beck RW;
    Pediatr Diabetes; 2017 Nov; 18(7):566-573. PubMed ID: 27758023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus.
    Rosa JS; Flores RL; Oliver SR; Pontello AM; Zaldivar FP; Galassetti PR
    Pediatr Diabetes; 2008 Feb; 9(1):9-16. PubMed ID: 18211631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic control and insulin requirements in type 1 diabetic patients depending on the clinical characteristics at diabetes onset.
    Beato-Víbora PI; Tormo-García MÁ
    Endocr Res; 2014; 39(2):86-90. PubMed ID: 24152206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poincaré plot quantification for assessing glucose variability from continuous glucose monitoring systems and a new risk marker for hypoglycemia: application to type 1 diabetes patients switching to continuous subcutaneous insulin infusion.
    Crenier L
    Diabetes Technol Ther; 2014 Apr; 16(4):247-54. PubMed ID: 24237387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathy.
    Zehetner C; Kirchmair R; Kralinger M; Kieselbach G
    Acta Ophthalmol; 2013 Sep; 91(6):e470-3. PubMed ID: 23452413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of insulin pump therapy on long-term glycemic control in a pediatric Spanish cohort.
    Colino E; Martín-Frías M; Yelmo R; Álvarez MÁ; Roldán B; Barrio R
    Diabetes Res Clin Pract; 2016 Mar; 113():69-76. PubMed ID: 26972965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.